PolarityTE Inc PTEIQ
Dividend Summary
The previous PolarityTE Inc dividend was 33.55c and it went ex over 8 years ago and it was paid over 8 years ago.
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | – |
| Type | Special | – |
| Per share | 33.55c | – |
| Declaration date | 06 Jan 2016 (Wed) | – |
| Ex-div date | 19 Jan 2016 (Tue) | – |
| Pay date | 15 Jan 2016 (Fri) | – |
Enter the number of PolarityTE Inc shares you hold and we'll calculate your dividend payments:
Sign up for PolarityTE Inc and we'll email you the dividend information when they declare.
Add PolarityTE Inc to receive free notifications when they declare their dividends.
Your account is set up to receive PolarityTE Inc notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Paid | Special | 06 Jan 2016 | 19 Jan 2016 | 15 Jan 2016 | USD | — | 33.55c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 0.0c | 0% |
| 2013 | 0.0c | 0% |
| 2014 | 0.0c | 0% |
| 2015 | 0.0c | 0% |
| 2016 | 0.0c | 0% |
| 2017 | 0.0c | 0% |
| 2018 | 0.0c | 0% |
| 2019 | 0.0c | 0% |
| 2020 | 0.0c | 0% |
| 2021 | 0.0c | 0% |
| 2022 | 0.0c | 0% |
| 2023 | 0.0c | 0% |
| 2024 | Sign Up Required | |
PolarityTE Inc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 28 April 2023
- 52 Week Low
- 0.0% on 28 April 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About PolarityTE Inc
PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The Company's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $0.24 (yesterday's closing price)
- Shares in Issue
- 7 million
- Market Cap
- $2mn
- 0
- Market Indices
- none
